Subgroup Analysis of Patients with Cancer in XALIA: A Noninterventional Study of Rivaroxaban versus Standard Anticoagulation for VTE by Walter Ageno, Lorenzo G. Mantovani, Sylvia Haas, Reinhold Kreutz, Danja Monje, Jonas Schneider, Martin van Eickels, Martin Gebel, Alexander G. G. Turpie

Get full text

Patient Management Strategies and Long-Term Outcomes in Isolated Distal Deep-Vein Thrombosis versus Proximal Deep-Vein Thrombosis: Findings from XALIA by Walter Ageno, Lorenzo G. Mantovani, Sylvia Haas, Reinhold Kreutz, Danja Monje, Jonas Schneider, Jörg-Peter Bugge, Martin Gebel, Alexander G. G. Turpie

Get full text

Anticoagulant treatment for venous thromboembolism: A pooled analysis and additional results of the XALIA and XALIA‐LEA noninterventional studies by Sylvia Haas, Lorenzo G. Mantovani, Reinhold Kreutz, Danja Monje, Jonas Schneider, Elizabeth R. Zell, Miriam Tamm, Martin Gebel, Jörg‐Peter Bugge, Walter Ageno, Alexander G. G. Turpie

Get full text

Characteristics and Effect of Rivaroxaban on Venous Thromboembolism in Korean Patients Compared to Western Population: A Subgroup Analysis from XALIA(-LEA) Study by Seung-Kee Min, Ji-Sun Kim, Jang Yong Kim, Ui Jun Park, Taehoon Lee, Jin Mo Kang, Sun Cheol Park, Won-Il Choi, Ki-Hyuk Park, Martin Gebel

Get full text

Patient-Reported Treatment Experience with Oral Rivaroxaban: Results from the Noninterventional XALIA Study of Deep-Vein Thrombosis by Stefan Cano, Lorenzo Mantovani, Kerstin Folkerts, Martin Gebel, Kurtulus Sahin, Elizabeth Zell, Danja Monje, Jonas Schneider, Martin van Eickels, Sylvia Haas, Reinhold Kreutz, Walter Ageno, Alexander G. G. Turpie

Get full text